144
0001944119
XXXXXXXX
LIVE
0001818331
GeneDx Holdings Corp.
001-39482
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
888-729-1206
Kevin Feeley
Officer
Class A Common Stock
Morgan Stanley Smith Barney
2000 Westchester Avenue
Purchase
NY
10577
5805
625400
28726248
09/30/2025
NASDAQ
Class A Common Stock
Merrill Lynch
2049 Century Park E
Ste 1200
Los Angeles
CA
90067
6609
716260
28726248
09/30/2025
NASDAQ
Class A Common Stock
05/02/2022
Acquired as compensation - Restricted Stock Units
Issuer
N
758
05/02/2022
Compensation
Class A Common Stock
09/01/2022
Acquired as compensation - Restricted Stock Units
Issuer
N
713
09/01/2022
Compensation
Class A Common Stock
09/01/2022
Acquired as compensation - Stock Options
Issuer
N
1246
09/01/2022
Compensation
Class A Common Stock
12/09/2022
Acquired as compensation - Restricted Stock Units
Issuer
N
2474
12/09/2022
Compensation
Class A Common Stock
04/26/2023
Acquired as compensation - Restricted Stock Units
Issuer
N
7223
04/26/2023
Compensation
N
Kevin Feeley
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
07/01/2025
1344
122471
Kevin Feeley
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
07/09/2025
5278
490854
Kevin Feeley
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
07/29/2025
388
40860
Kevin Feeley
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
09/02/2025
378
47556
Kevin Feeley
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
09/09/2025
1272
162886
Kevin Feeley
333 Ludlow St, North Tower
6th Floor
Stamford
CT
06902
Class A Common Stock
09/16/2025
3728
452840
Represents approximately 12,414 shares to be sold on behalf of the Reporting Person, including 1) approximately 393 shares to be sold in connection with the anticipated vesting of RSUs on October 29, 2025; 2) approximately 374 shares to be sold in connection with the anticipated vesting of RSUs on December 1, 2025; 3) approximately 1,284 shares to be sold in connection with the anticipated vesting of RSUs on December 9, 2025; 4) approximately 3,754 shares to be sold in connection with the anticipated vesting of RSUs on December 16, 2025; and 5) 6,609 shares to be sold by the Reporting Person pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 21, 2024. Shares sold in the past 3 months by the Reporting Person include: 1) 5,766 shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs; and 2) 6,622 shares in connection with sales pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on August 21, 2024.
09/30/2025
08/21/2024
/s/ Kevin Feeley